当前位置:首页 - 行情中心 - 科前生物(688526) - 财务分析

科前生物

(688526)

  

流通市值:68.89亿  总市值:68.89亿
流通股本:4.66亿   总股本:4.66亿

科前生物(688526)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.79亿元,每股收益0.17元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益431240.97万元,未分配利润244916.26万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产482457.42万元,负债51216.45万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入227,536,944.76949,742,023.06737,863,251.81487,290,650.57
营业总成本135,315,536.88524,371,080.48401,181,258.98257,541,676.39
其他经营收益
营业利润90,202,180.95483,114,299.61390,312,391.04253,742,611.24
利润总额90,104,990.22481,540,786.27388,971,331.63253,574,907.97
净利润78,689,127.68416,941,266.13336,604,771.84219,277,761.2
每股收益
其他综合收益-7,104,812.0481,279,244.3447,672,522.1550,736,402.83
综合收益总额71,584,315.64498,220,510.47384,277,293.99270,014,164.03
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计3,110,002,104.342,927,075,209.452,623,048,563.62,488,160,848.66
非流动资产:
非流动资产合计1,714,572,106.091,862,130,073.812,129,978,898.432,087,178,432.88
资产总计4,824,574,210.434,789,205,283.264,753,027,462.034,575,339,281.54
流动负债:
流动负债合计419,166,319.14457,496,389.03495,111,884.23435,314,172.13
非流动负债:
非流动负债合计92,998,222.5592,530,569.0485,099,575.7884,998,694.41
负债合计512,164,541.69550,026,958.07580,211,460.01520,312,866.54
所有者权益(或股东权益):
归属于母公司股东权益合计4,312,559,249.894,238,780,870.214,171,949,496.464,053,591,441.34
股东权益合计4,312,409,668.744,239,178,325.194,172,816,002.024,055,026,415
负债和股东权益合计4,824,574,210.434,789,205,283.264,753,027,462.034,575,339,281.54
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计223,312,296.42946,097,003.53769,938,493.15488,335,269.01
经营活动现金流出小计172,840,733.12477,555,170.31454,224,365.56314,009,274.33
经营活动产生的现金流量净额50,471,563.3468,541,833.22315,714,127.59174,325,994.68
投资活动产生的现金流量:
投资活动现金流入小计1,071,865,724.341,418,469,452.571,786,395,731.32674,042,015.34
投资活动现金流出小计1,099,982,054.492,067,361,820.392,185,017,604.22613,201,871.38
投资活动产生的现金流量净额-28,116,330.15-648,892,367.82-398,621,872.960,840,143.96
筹资活动产生的现金流量:
筹资活动现金流入小计-17,692,58417,692,58417,692,584
筹资活动现金流出小计576,250.38201,962,377.1201,250,823.46201,007,316.38
筹资活动产生的现金流量净额-576,250.38-184,269,793.1-183,558,239.46-183,314,732.38
汇率变动对现金及现金等价物的影响-9,243.55-2,056,879.58-47,468.47-505,291.59
现金及现金等价物净增加额21,769,739.22-366,677,207.28-266,513,453.2451,346,114.67
期末现金及现金等价物余额198,571,124.68176,801,385.46276,965,139.5594,824,707.41
补充资料:
现金及现金等价物的净增加额--366,677,207.28-51,346,114.67
最新报告期:2026-05-12
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华创证券陈鹏0.881.091.262026-05-12
东兴证券程诗月0.931.121.272026-04-30
财通证券肖珮菁0.911.021.172026-04-30
申万宏源朱珺逸0.941.001.142026-04-30
中信证券施杨,盛夏,彭家乐0.901.091.232026-04-16
TOP↑